[시장보고서]방사선량 관리 시장 - 세계 및 지역별 분석 : 제품별, 모달리티별, 도입 형태별, 용도별, 최종사용자별, 국가별

방사선량 관리 시장 - 세계 및 지역별 분석 : 제품별, 모달리티별, 도입 형태별, 용도별, 최종사용자별, 국가별 - 분석과 예측(2025-2035년)

Radiation Dose Management Market - A Global and Regional Analysis: Focus on Product, Modality, Mode of Deployment, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035

상품코드 : 1694064

리서치사 : BIS Research

발행일 : 2025년 04월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 방사선량 관리 시장 규모는 2035년까지 10.45%의 CAGR로 성장할 것으로 예상됩니다.

세계 방사선량 관리 시장의 성장은 진단적 개입이 필요한 만성질환의 유병률 증가, 중재적 방사선학(IR)에 대한 관심 증가, 환자의 안전과 전리방사선 과다 노출로 인한 유해한 생물학적 영향에 대한 인식이 높아짐에 따라 견인될 것으로 예상됩니다.

방사선량 관리 시장은 신흥 시장 단계에 있습니다. 온클라우드 선량 관리 솔루션의 개발과 소아 수술에서 방사선량 관리에 대한 노력의 증가는 세계 방사선량 관리 시장에서 큰 기회 중 하나입니다. 또한, 시장에서 진행 중인 주요 동향으로는 방사선량을 줄이는 기술을 이용한 영상 양식의 개발 증가, 시장을 독점하는 파트너십 및 전략적 사업 제휴, 시장 진입 기업 간의 다양한 협력 관계 등을 들 수 있습니다.

세계 방사선량 관리 시장(모달리티별)은 2024년 CT 스캐너 부문이 지배적이었으며, 이러한 추세는 2025-2035년 말까지 지속될 것으로 예측됩니다. 제품별로는 Radimetrics Enterprise Platform이 가장 큰 비중을 차지하고 있으며, DoseWatch가 그 뒤를 잇고 있습니다. 도입 형태별로는 웹 기반 부문이 가장 큰 비중을 차지하고 있습니다. 최종사용자별로는 병원이 압도적인 점유율을 차지하고 있습니다.

방사선 장비의 설치 대수 증가와 스캔 횟수 증가로 방사선 피폭의 위험이 증가함에 따라 선량 관리 솔루션에 대한 수요가 증가하고 있습니다. 심혈관질환의 유병률 증가와 카테터 검사실에서의 산업재해 증가로 인해 방사선 피폭의 영향에 대한 우려가 커지고 있습니다. 중재적 방사선학(IR)에 대한 관심이 높아짐에 따라 IR 이미징 시스템에 대한 수요가 증가하고 방사선 피폭의 위험성이 높아질 것으로 예상됩니다. 방사선 과다 피폭에 대한 우려가 높아지면서 선량 관리 솔루션의 채택률이 증가하고 있습니다. 방사선량 관리에 대한 인식과 노력이 높아짐에 따라 선량관리 소프트웨어의 도입이 증가할 것으로 예상됩니다. 각국의 선량 최적화 및 벤치마킹의 발전은 의료기관의 선량 관리 소프트웨어 채택을 촉진할 것입니다.

제품 유형은 병원 및 진단센터에서 사용할 수 있는 다양한 유형의 방사선량 관리 소프트웨어를 이해하는 데 도움이 됩니다. 또한, 대응 모달리티(CT 스캐너, 엑스레이, CR, DR, 유방촬영시스템, 중재적 혈관조영시스템/혈관조영시스템/안지오CT, 투시시스템, PET 스캐너, SPECT, 하이브리드 이미징), 도입 형태(클라우드 기반, 웹 기반, 온프레미스), 도입 가능한 최종사용자(병원, 진단센터, 기타)를 기반으로 다양한 방사선량 관리 소프트웨어의 종류를 파악할 수 있습니다. 도입 가능한 최종사용자(병원, 진단센터, 기타)를 기준으로 다양한 방사선량 관리 소프트웨어를 상세히 이해할 수 있습니다.

세계 방사선량 관리 시장에서는 주요 기업들의 파트너십, 제휴, 사업 확장, 신제품 출시 등의 시장 개척을 볼 수 있습니다. 파트너십이 가장 많으며, 세계 방사선량 관리 시장 전체 개발의 70.00% 가량을 차지하고 있습니다.

세계의 방사선량 관리 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 모달리티별, 도입 형태별, 용도별, 최종사용자별, 국가별 동향, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.

Agfa-Gevaert Group
Bracco
Bayer AG
Canon Inc.
FUJIFILM Holdings Corporation
Guerbet
General Electric Company
Imalogix
Infinitt Healthcare Co., Ltd.
LANDAUER
Medsquare
Medic Vision Imaging Solutions Ltd.
MyXrayDose Ltd.
Novarad Corporation
PACSHealth, LLC
Qaelum NV
Sectra AB
SST Group Inc.
Siemens Healthineers AG
Virtual Phantoms Inc.

ksm

영문 목차

영문목차

Global Radiation Dose Management Market: Industry Overview

The global radiation dose management market is expected to grow at a CAGR of 10.45% by 2035. The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation.

Market Lifecycle Stage

The radiation dose management market is in the developing phase. The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players.

Market Segmentation:

Segmentation 1: by Modality

CT Scanners
X-Ray, CR, and DR
Mammography Systems
Interventional Angiography Systems/Angio CT
Fluoroscopy Systems
PET Scanners and SPECT
Hybrid Imaging

The global radiation dose management market (by modality) was dominated by the CT scanners segment in 2024, and the trend is expected to continue till the end of the forecast period 2025-2035.

Segmentation 2: by Product

Radimetrics Enterprise Platform
DoseWatch and DoseWatch Explore
teamplay Dose
NEXO [DOSE]
tqm/Dose and DoseMonitor
Radiation Dose Monitor
Imalogix Platform
Syncro-Dose
NovaDose
DoseWise Portal
SafeCT
MyXrayDose
DoseM
Dose Tracking System
DoseTrack

The global radiation dose management market (by product) is dominated by the Radimetrics Enterprise Platform, followed by DoseWatch.

Segmentation 3: by Mode of Deployment

Web-Based
On-Premise
Cloud-Based

The global radiation dose management market (by mode of deployment) is dominated by the web-based segment.

Segmentation 4: by Application

Oncology
Cardiology
Orthopedic
Other Application

The global radiation dose management market (by application) is dominated by the oncology segment.

Segmentation 5: by End User

Hospitals
Diagnostic Centers
Others

The global radiation dose management market (by end user) is dominated by the hospitals segment.

Segmentation 6: by Region

North America- U.S. and Canada
Europe- Germany, France, U.K., Italy, Spain, Netherlands, and Rest-of-Europe
Asia-Pacific- Japan, China, India, Australia and New Zealand, South Korea, and Rest-of-Asia-Pacific
Latin America- Brazil, Mexico, and Rest-of-Latin America
Middle East and Africa

Recent Developments in the Global Radiation Dose Management Market

In December 2020, Bayer AG launched Radimetrics v3.0, the latest evolution of its enterprise dose management utility.
In December 2020, FUJIFILM Holdings Corporation launched the unique SYNAPSE Dose 2.0 to provide a comprehensive system for managing patient radiation exposure across several imaging modalities.
In January 2020, Agfa HealthCare collaborated with Maasstad Hospital in the Netherlands to support advancements in the consistency and optimization of radiation doses.
In April 2019, Qaelum NV signed an agreement with TOYO Corporation to distribute its dose monitoring solution, DOSE, in Japan.
In January 2019, SST Group, Inc. partnered with Intermountain Healthcare to implement a software platform for the Radiation Dose Monitor (RDM). The software platform permits medical professionals to manage, examine, and optimize the dose delivered to a patient during interventional procedures, medical imaging examinations, and image-guided surgery.
In August 2018, Imalogix launched a newer version of its radiation dose management platform with additional fluoroscopy capabilities. The software solution can automatically calculate the peak skin dose for the patient during a fluoroscopic procedure.
In August 2018, Guerbet LLC USA, a subsidiary of the Guerbet Group, partnered with Imalogix to decrease inconsistency and advance the quality, safety, and competence of care around radiation dose management, to enable the network health system and member facilities to monitor patient radiation dose on a per-procedure and cumulative basis.
In March 2018, PACSHealth, LLC launched DoseMonitor, a radiation dose management software for tracking radiation dose absorption.

Demand - Drivers and Limitations

Following are the drivers for the global radiation dose management market:

Increasing installed bases of radiology equipment and the number of scans lead to a higher risk of radiation exposure, thus creating demand for dose management solutions.
The increasing prevalence of cardiovascular diseases and growing occupational hazards in cath labs lead to the growing concern surrounding the effects of radiation exposure.
Growing focus on interventional radiology (IR) is expected to increase demand for IR imaging systems and subsequently lead to a higher risk of radiation exposure.
Increasing concern related to radiation overexposure is leading to higher adoption of dose management solutions.
Growing awareness and initiatives for radiation dose management are expected to push the adoption of dose management software.
Advancements in dose optimization and benchmarking in various countries will encourage healthcare institutions to adopt dose management software.

The market is expected to face some limitations as well due to the following challenges:

The lack of awareness among the population and the shortage of skilled and trained professionals leading to a steep learning curve hinders the adoption of dose management software.
The lack of diagnostic reference levels (DRLs) for radiation dose benchmarking in low-income countries causes healthcare institutions to not pursue the adoption of dose management software with vigor.

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different types of radiation dose management software available for use in hospitals and diagnostic centers. Moreover, the study provides the reader with a detailed understanding of the different radiation dose products based on the modalities they are compatible with (CT scanners, X-Ray, CR, and DR, mammography system, interventional angiography systems/angio CT, fluoroscopy systems, PET scanners and SPECT, and hybrid imaging), the modes on which they can be deployed (cloud-based, web-based, and on-premises), and the end users who can adopt such software (hospitals, diagnostic centers, and others).

Growth/Marketing Strategy: The global radiation dose management market has seen developments by key players operating in the market, such as partnerships, collaborations and business expansions, and new product launches. Partnerships accounted for the maximum number of key developments, i.e., nearly 70.00% of the total developments in the global radiation dose management market.

Competitive Strategy: Key players in the global radiation dose management market analyzed and profiled in the study involve players that offer radiation dose software. Moreover, a detailed market share analysis of the players operating in the global radiation dose management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the key players in this market are:

Agfa-Gevaert Group
Sectra AB
Bracco
Guerbet
Canon Inc.
General Electric Company
FUJIFILM Holdings Corporation
Imalogix
Infinitt Healthcare Co. Ltd.
Koninklijke Philips N.V.
Medic Vision Imaging Solutions Ltd.
Medsquare
MyXrayDose Ltd.
PACSHealth, LLC
Qaelum NV
Bayer AG
SST Group Inc.
Siemens Healthineers AG

Companies that are not a part of the previously mentioned pool have been well represented across different sections of the report (wherever applicable).

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

Research Methodology

1. Market Overview

1.1 Overview
- 1.1.1 Natural Radiation Sources
- 1.1.2 Biological Effects of Radiation
- 1.1.3 Usage of Radiation in Medical Devices
- 1.1.4 Radiation Dose
- 1.1.5 Effective Radiation Dose
- 1.1.6 Factors Contributing to Unnecessary Radiation Exposure
- 1.1.7 Radiation Exposure Trend
1.2 Key Trends
1.3 Opportunity Assessment
1.4 Patent Analysis
1.5 Comparative Analysis
1.6 Market Gap Analysis
1.7 Pricing Analysis
1.8 Change in Competitive Landscape and Product Demand

2. Market Dynamics

2.1 Overview
- 2.1.1 Impact Analysis
2.2 Market Drivers
2.3 Market Restraints
2.4 Market Opportunities

3. Global Radiation Dose Management Market: Competitive Landscape

3.1 Overview
3.2 Corporate Strategies
- 3.2.1 Mergers and Acquisitions
- 3.2.2 Synergistic Activities
- 3.2.3 Business Expansions and Funding
3.3 Business Strategies
- 3.3.1 Product Launches and Approvals
- 3.3.2 Publications
- 3.3.3 Licenses and Agreements
- 3.3.4 Other Activities
3.4 Market Share Analysis

4. Global Radiation Dose Management Market (by Modality), Value ($million), 2023-2035

4.1 Overview
4.2 CT Scanners
4.3 X-Ray, CR, and DR
4.4 Mammography Systems
4.5 Interventional Angiography Systems/Angio CT
4.6 Fluoroscopy Systems
4.7 PET Scanners and SPECT
4.8 Hybrid Imaging

5. Global Radiation Dose Management Market (by Product), Value ($million), 2023-2035

5.1 Overview
5.2 Radimetrics Enterprise Platform
- 5.2.1 Key Features
- 5.2.2 Radimetrics Enterprise Platform- Global Market
- 5.2.3 Installed Base
- 5.2.4 Compatible Modalities
- 5.2.5 Competitive Benchmarking
5.3 DoseWatch and DoseWatch Explore
- 5.3.1 Key Features
- 5.3.2 DoseWatch and DoseWatch Explore- Global Market
- 5.3.3 Installed Base
- 5.3.4 Compatible Modalities
- 5.3.5 Competitive Benchmarking
5.4 teamplay Dose
- 5.4.1 Key Features
- 5.4.2 teamplay Dose- Global Market
- 5.4.3 Installed Base
- 5.4.4 Compatible Modalities
- 5.4.5 Competitive Benchmarking
5.5 NEXO [DOSE]
- 5.5.1 Key Features
- 5.5.2 NEXO [DOSE]- Global Market
- 5.5.3 Installed Base
- 5.5.4 Compatible Modalities
- 5.5.5 Competitive Benchmarking
5.6 tqm/Dose and DoseMonitor
- 5.6.1 Key Features
- 5.6.2 tqm/Dose and DoseMonitor- Global Market
- 5.6.3 Installed Base
- 5.6.4 Compatible Modalities
- 5.6.5 Competitive Benchmarking
5.7 Radiation Dose Monitor
- 5.7.1 Key Features
- 5.7.2 Radiation Dose Monitor- Global Market
- 5.7.3 Installed Base
- 5.7.4 Compatible Modalities
- 5.7.5 Competitive Benchmarking
5.8 Imalogix Platform
- 5.8.1 Key Features
- 5.8.2 Imalogix Platform- Global Market
- 5.8.3 Installed Base
- 5.8.4 Compatible Modalities
- 5.8.5 Competitive Benchmarking
5.9 Syncro-Dose
- 5.9.1 Key Features
- 5.9.2 Syncro-Dose- Global Market
- 5.9.3 Installed Base
- 5.9.4 Compatible Modalities
- 5.9.5 Competitive Benchmarking
5.10 NovaDose
- 5.10.1 Key Features
- 5.10.2 NovaDose- Global Market
- 5.10.3 Installed Base
- 5.10.4 Compatible Modalities
- 5.10.5 Competitive Benchmarking
5.11 DoseWise Portal
- 5.11.1 Key Features
- 5.11.2 DoseWise Portal- Global Market
- 5.11.3 Installed Base
- 5.11.4 Compatible Modalities
- 5.11.5 Competitive Benchmarking
5.12 SafeCT
- 5.12.1 Key Features
- 5.12.2 SafeCT- Global Market
- 5.12.3 Installed Base
- 5.12.4 Compatible Modalities
- 5.12.5 Competitive Benchmarking
5.13 MyXrayDose
- 5.13.1 Key Features
- 5.13.2 MyXrayDose- Global Market
- 5.13.3 Installed Base
- 5.13.4 Compatible Modalities
- 5.13.5 Competitive Benchmarking
5.14 DoseM
- 5.14.1 Key Features
- 5.14.2 DoseM- Global Market
- 5.14.3 Installed Base
- 5.14.4 Compatible Modalities
- 5.14.5 Competitive Benchmarking
5.15 Dose Tracking System
- 5.15.1 Key Features
- 5.15.2 Dose Tracking System- Global Market
- 5.15.3 Installed Base
- 5.15.4 Compatible Modalities
- 5.15.5 Competitive Benchmarking
5.16 DoseTrack
- 5.16.1 Key Features
- 5.16.2 DoseTrack- Global Market
- 5.16.3 Installed Base
- 5.16.4 Compatible Modalities
- 5.16.5 Competitive Benchmarking

6. Global Radiation Dose Management Market (by Mode of Deployment), Value ($Million), 2023-2035

6.1 Overview
6.2 Web-Based
6.3 On-Premises
6.4 Cloud Based

7. Global Radiation Dose Management Market (by Application), Value ($Million), 2023-2035

7.1 Overview
7.2 Oncology
7.3 Cardiology
7.4 Orthopaedics
7.5 Other Applications

8. Global Radiation Dose Management Market (by End User), Value ($Million), 2023-2035

8.1 Overview
8.2 Hospitals
8.3 Diagnostic Centers
8.4 Others

9. Global Radiation Dose Management Market (by Region), Value ($Million), 2023-2035

9.1 Overview
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 France
- 9.3.3 U.K
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Netherlands
- 9.3.7 Rest-of-Europe
9.4 Asia-Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia & New Zealand
- 9.4.5 South Korea
- 9.4.6 Rest-of-Asia-Pacific (RoAPAC)
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest-of-Latin America
9.6 Middle East and Africa
- 9.6.1 Middle East
- 9.6.2 Africa

10. Company Profiles

10.1 Agfa-Gevaert Group
- 10.1.1 Company Overview
- 10.1.2 Product Portfolio
- 10.1.3 Target Customers/ End Users
- 10.1.4 Analyst View
10.2 Bracco
- 10.2.1 Company Overview
- 10.2.2 Product Portfolio
- 10.2.3 Target Customers/ End Users
- 10.2.4 Analyst View
10.3 Bayer AG
- 10.3.1 Company Overview
- 10.3.2 Product Portfolio
- 10.3.3 Target Customers/ End Users
- 10.3.4 Analyst View
10.4 Canon Inc.
- 10.4.1 Company Overview
- 10.4.2 Product Portfolio
- 10.4.3 Target Customers/ End Users
- 10.4.4 Analyst View
10.5 FUJIFILM Holdings Corporation
- 10.5.1 Company Overview
- 10.5.2 Product Portfolio
- 10.5.3 Target Customers/ End Users
- 10.5.4 Analyst View
10.6 Guerbet
- 10.6.1 Company Overview
- 10.6.2 Product Portfolio
- 10.6.3 Target Customers/ End Users
- 10.6.4 Analyst View
10.7 General Electric Company
- 10.7.1 Company Overview
- 10.7.2 Product Portfolio
- 10.7.3 Target Customers/ End Users
- 10.7.4 Analyst View
10.8 Imalogix
- 10.8.1 Company Overview
- 10.8.2 Product Portfolio
- 10.8.3 Target Customers/ End Users
- 10.8.4 Analyst View
10.9 Infinitt Healthcare Co., Ltd.
- 10.9.1 Company Overview
- 10.9.2 Product Portfolio
- 10.9.3 Target Customers/ End Users
- 10.9.4 Analyst View
10.10 LANDAUER
- 10.10.1 Company Overview
- 10.10.2 Product Portfolio
- 10.10.3 Target Customers/ End Users
- 10.10.4 Analyst View
10.11 Medsquare
- 10.11.1 Company Overview
- 10.11.2 Product Portfolio
- 10.11.3 Target Customers/ End Users
- 10.11.4 Analyst View
10.12 Medic Vision Imaging Solutions Ltd.
- 10.12.1 Company Overview
- 10.12.2 Product Portfolio
- 10.12.3 Target Customers/ End Users
- 10.12.4 Analyst View
10.13 MyXrayDose Ltd.
- 10.13.1 Company Overview
- 10.13.2 Product Portfolio
- 10.13.3 Target Customers/ End Users
- 10.13.4 Analyst View
10.14 Novarad Corporation
- 10.14.1 Company Overview
- 10.14.2 Product Portfolio
- 10.14.3 Target Customers/ End Users
- 10.14.4 Analyst View
10.15 PACSHealth, LLC
- 10.15.1 Company Overview
- 10.15.2 Product Portfolio
- 10.15.3 Target Customers/ End Users
- 10.15.4 Analyst View
10.16 Qaelum NV
- 10.16.1 Company Overview
- 10.16.2 Product Portfolio
- 10.16.3 Target Customers/ End Users
- 10.16.4 Analyst View
10.17 Sectra AB
- 10.17.1 Company Overview
- 10.17.2 Product Portfolio
- 10.17.3 Target Customers/ End Users
- 10.17.4 Analyst View
10.18 SST Group Inc.
- 10.18.1 Company Overview
- 10.18.2 Product Portfolio
- 10.18.3 Target Customers/ End Users
- 10.18.4 Analyst View
10.19 Siemens Healthineers AG
- 10.19.1 Company Overview
- 10.19.2 Product Portfolio
- 10.19.3 Target Customers/ End Users
- 10.19.4 Analyst View
10.20 Virtual Phantoms Inc.
- 10.20.1 Company Overview
- 10.20.2 Product Portfolio
- 10.20.3 Target Customers/ End Users
- 10.20.4 Analyst View

한글목차

목차

주요 요약

제1장 시장 개요

제2장 시장 역학

제3장 세계의 방사선량 관리 시장 : 경쟁 구도

제4장 세계의 방사선량 관리 시장(모달리티별), 금액(100만 달러), 2023-2035년

제5장 세계의 방사선량 관리 시장(제품별), 금액(100만 달러), 2023-2035년

제6장 세계의 방사선량 관리 시장(도입 형태별), 금액(100만 달러), 2023-2035년

제7장 세계의 방사선량 관리 시장(용도별), 금액(100만 달러), 2023-2035년

제8장 세계의 방사선량 관리 시장(최종사용자별), 금액(100만 달러), 2023-2035년

제9장 세계의 방사선량 관리 시장(지역별), 금액(100만 달러), 2023-2035년

제10장 기업 개요